Survival outcomes in metastatic castration-resistant prostate cancer in the up-front treatment era.

被引：0
|
作者：
Kamijo, Shunsuke
Naito, Yushi
Kato, Masashi
Yamamoto, Akiyuki
Tsuzuki, Toyonori
机构：
[1] Nagoya Univ, Grad Sch Med, Nagoya, Japan
[2] Nagoya Univ Hosp, Dept Urol, Nagoya, Japan
[3] Nagoya Univ, Grad Sch Med, Showa Ku, Nagoya, Japan
[4] Toyohashi Municipal Hosp, Toyohashi, Japan
[5] Aichi Med Univ, Nagakute, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
336
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Optimal sequential therapy for metastatic castration-resistant prostate cancer after androgen receptor pathway inhibitors in the up-front era.
    Naito, Yushi
    Nagayama, Jun
    Sano, Yuta
    Inoue, Satoshi
    Matsuo, Kazuna
    Sano, Tomoyasu
    Ishida, Shohei
    Matsukawa, Yoshihisa
    Kato, Masashi
    Akamatsu, Shusuke
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 168 - 168
  • [2] Treatment of metastatic, castration-resistant prostate cancer
    von Amsberg, G.
    Merseburger, A. S.
    UROLOGE, 2020, 59 (06): : 673 - 679
  • [3] Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
    Hussain, Maha
    Mateo, Joaquin
    Fizazi, Karim
    Saad, Fred
    Shore, Neal
    Sandhu, Shahneen
    Chi, Kim N.
    Sartor, Oliver
    Agarwal, Neeraj
    Olmos, David
    Thiery-Vuillemin, Antoine
    Twardowski, Przemyslaw
    Roubaud, Guilhem
    Ozguroglu, Mustafa
    Kang, Jinyu
    Burgents, Joseph
    Gresty, Christopher
    Corcoran, Claire
    Adelman, Carrie A.
    de Bono, Johann
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (24): : 2345 - 2357
  • [4] Survival outcomes of metastatic castration-resistant prostate cancer in Brazil (LACOG 1818).
    Maluf, Fernando Cotait
    S. Martins, Suelen P.
    Vieira Silva Neto, Deusdedit Cortez
    Werutsky, Gustavo
    Rinck, Jose Augusto, Jr.
    Bastos, Diogo Assed
    Rocha, Roberto Odebrecht
    Fernandes, Roni de Carvalho
    Girardi, Daniel da Motta
    Araujo, Daniel Vilarim
    Mota, Augusto C. A.
    Lara Gongora, Aline Bobato
    Fernandes, Bruno Melo
    Fonseca Alves, Ana Caroline
    Anjos Tavares Sampaio, Cristina de Deus
    Ponte de Souza, Andrea Lopes
    de Jesus, Rafaela Gomes
    de Lima Gossling, Gustavo Cartaxo
    Soares, Andrey
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [5] Abiraterone in the treatment of metastatic castration-resistant prostate cancer
    Mostaghel, Elahe A.
    CANCER MANAGEMENT AND RESEARCH, 2014, 6 : 39 - 51
  • [6] Monitoring of treatment for metastatic castration-resistant prostate cancer
    Hinz, Stefan
    AKTUELLE UROLOGIE, 2017, 48 (03) : 225 - 229
  • [7] Talazoparib for the Treatment of Metastatic Castration-resistant Prostate Cancer
    Qureshi, Zaheer
    Fatima, Eeshal
    Safi, Adnan
    Khanzada, Mikail
    Altaf, Faryal
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2025, 48 (04): : 206 - 214
  • [8] Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
    Rodriguez-Vida, Alejo
    Galazi, Myria
    Rudman, Sarah
    Chowdhury, Simon
    Sternberg, Cora N.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 3325 - 3339
  • [9] Perspectives on Treatment of Metastatic Castration-Resistant Prostate Cancer
    Merseburger, Axel S.
    Bellmunt, Joaquim
    Jenkins, Cheryl
    Parker, Chris
    Fitzpatrick, John M.
    ONCOLOGIST, 2013, 18 (05): : 558 - 567
  • [10] Survival Outcomes of Concurrent Treatment with Docetaxel and Androgen Deprivation Therapy in Metastatic Castration-Resistant Prostate Cancer
    Jang, Ho Seong
    Koo, Kyo Chul
    Cho, Kang Su
    Chung, Byung Ha
    YONSEI MEDICAL JOURNAL, 2016, 57 (05) : 1070 - 1078
12345